Cargando…

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

BACKGROUND: In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (CNS) relapse is uncommon but is nearly always fatal. This study aimed to determine the risk factors for CNS relapse in DLBCL patients and to evaluate the efficacy of rituximab and intrathecal chemotherapy pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Qing-Qing, Hu, Li-Yang, Geng, Qi-Rong, Chen, Jie, Lu, Zhen-Hai, Rao, Hui-Lan, Liu, Qing, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022242/ https://www.ncbi.nlm.nih.gov/pubmed/27624700 http://dx.doi.org/10.1186/s40880-016-0150-y

Ejemplares similares

P1143: ZANUBRUTINIB PLUS CYTARABINE IN PATIENTS WITH REFRACTORY/RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Lin, Zhiguang, et al.
Publicado: (2023)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Pretreatment diffusion-weighted imaging for prediction of relapsed and refractory primary central nervous system lymphoma
por: Chien, Hsi-Cheng, et al.
Publicado: (2023)

Unusual relapse of primary central nervous system lymphoma
por: Igala, Marielle
Publicado: (2016)

Primary cardiac lymphoma with central nervous system relapse
por: van Rooijen, Cleo R., et al.
Publicado: (2017)

Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma
por: Qualls, David, et al.
Publicado: (2019)

Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma
por: Isaev, Keren, et al.
Publicado: (2020)

Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma
por: Lin, Zhiguang, et al.
Publicado: (2023)

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
por: Ma, Jingjing, et al.
Publicado: (2022)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study
por: Hu, Li-Yang, et al.
Publicado: (2017)

Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report
por: Ma, Shuang, et al.
Publicado: (2018)

Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies
por: Raffa, Enass H., et al.
Publicado: (2021)

Pathology and new insights in central nervous system lymphomas
por: Lebrun, Laetitia, et al.
Publicado: (2023)

Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma
por: Hu, Rong, et al.
Publicado: (2013)

Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation
por: Wang, Song-Quan, et al.
Publicado: (2022)

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma
por: Chihara, Dai, et al.
Publicado: (2018)

Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
por: Bhansali, Rahul S., et al.
Publicado: (2023)

Implicit Attitudes of New-Type Drug Abstainers towards New-Type Drugs and Their Relapse Tendencies
por: Li, Guangming
Publicado: (2023)

Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study
por: Ma, Jingjing, et al.
Publicado: (2019)

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015)

Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma
por: Lee, Yong-Pyo, et al.
Publicado: (2023)

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
por: Thieblemont, Catherine, et al.
Publicado: (2023)

PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL
por: Yokus, Osman, et al.
Publicado: (2023)

Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma
por: Kim, Jeong Eun, et al.
Publicado: (2012)

Unusual Relapse of Primary Central Nervous System Lymphoma at Site of Lumbar Puncture
por: Ahmed, Zartaj, et al.
Publicado: (2014)

Central Nervous System Toxoplasmosis in Relapsed Hodgkin’s Lymphoma: A Case Report
por: Abolghasemi, Hassan, et al.
Publicado: (2016)

Late Central Nervous System Relapse in a Patient with Maxillary Sinus Lymphoma
por: Kewan, Tariq, et al.
Publicado: (2018)

CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
por: Vu, Khoan, et al.
Publicado: (2022)

Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology
por: Ahn, Yongchel, et al.
Publicado: (2017)

High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma
por: Shao, Jie, et al.
Publicado: (2020)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
por: Cabannes‐Hamy, Aurélie, et al.
Publicado: (2018)

Performance of diffusion and perfusion MRI in evaluating primary central nervous system lymphomas of different locations
por: Xing, Zhen, et al.
Publicado: (2020)

Magnetic Resonance Imaging Characteristics of Primary Central Nervous System T-cell Lymphoma
por: Zhao, Qing, et al.
Publicado: (2017)

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
por: Kobayashi, Keiichi, et al.
Publicado: (2020)

Extranodal NK/T-Cell Lymphoma Occurring Primarily in the Eyes and with Central Nervous System Relapse
por: Wei, Chong, et al.
Publicado: (2021)

Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
por: Nepal, Gaurav, et al.
Publicado: (2022)

Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma
por: Kaulen, Leon D, et al.
Publicado: (2022)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
por: T Low, Justin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ik1t0mlpjdfi13bu5i81oothld